news
We unravel disease mechanisms
news
Collaboration with NYU Langone Health in breast cancer
news
InnoSIGN starts offering OncoSIGNal pathway profiling services for clinical use in the US
events
Identifying mutation-independent signaling pathway activation in molecular subtypes of triple negative breast cancers
events
Meet InnoSIGN at Association for Molecular Pathology (AMP) 2023
events